CORC  > 山东大学
Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.
Li, Yan-Shuang; Yang, Qing; Qi, Ming; Li, Ji-Yu
刊名Molecular and clinical oncology
2017
卷号7期号:4
DOI10.3892/mco.2017.1351
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4686664
专题山东大学
作者单位1.Department of Neurology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
2.[ Yang
推荐引用方式
GB/T 7714
Li, Yan-Shuang,Yang, Qing,Qi, Ming,et al. Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.[J]. Molecular and clinical oncology,2017,7(4).
APA Li, Yan-Shuang,Yang, Qing,Qi, Ming,&Li, Ji-Yu.(2017).Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study..Molecular and clinical oncology,7(4).
MLA Li, Yan-Shuang,et al."Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.".Molecular and clinical oncology 7.4(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace